Welch Group
TCON

Welch Group’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Welch Group’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-299
Closed -$418K – 140
2016
Q1 		$418K Hold
299
– – 0.07% 69
2015
Q4 		$553K Buy
299
+130
+77% +$260K 0.1% 63
2015
Q3 		$330K Buy
+169
New +$395K 0.06% 70

Other funds holding TCON

NEA Management Company
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
QVT Financial
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Visium Asset Management
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
ClariVest Asset Management
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Welch Group's TCON Position: Q2 2016 in Review

Welch Group sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2016, closing a stake of 299 shares — an estimated $418K sold.

Welch Group first reported a position in TCON in Q3 2015 and held it in 3 quarters. The position peaked at $553K in Q4 2015. 25 funds tracked by Wall St. Rank hold TCON as of Q2 2016.

  • Welch Group reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Welch Group sold 299 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2016, an estimated $418K.
  • Welch Group first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q3 2015 and held it in 3 quarters.
  • Welch Group's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $553K in Q4 2015.
  • 25 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2016.

Based on Welch Group's 13F filing for Q2 2016, filed 28 Jul 2016.